⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GRI News
GRI Bio, Inc. Common Stock
GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights
globenewswire.com
GRI
GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF
globenewswire.com
GRI
GRI Bio Secures New U.S. Composition of Matter Patent Covering Novel Compound Structures
globenewswire.com
GRI
GRI Bio Announces Reverse Stock Split
globenewswire.com
GRI
GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621
globenewswire.com
GRI
GRI Bio Announces Closing of $8.0 Million Public Offering
globenewswire.com
GRI
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
globenewswire.com
GRI
GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
globenewswire.com
GRI